文献速递帕金森病与运动障碍认知障碍与痴呆

DTI-ALPS类淋巴指数与孤立性REM睡眠行为障碍不同表型转化的关联:多队列MRI研究

Association of DTI-ALPS Glymphatic Index With Differential Phenoconversion in Isolated REM Sleep Behavior Disorder: A Multi-Cohort MRI Study.
PubMed 文献 · Neurology · 2025-09-16

该多中心纵向队列研究纳入250例iRBD患者和178名对照,发现iRBD患者左侧DTI-ALPS指数低于对照(平均差-0.034,95%CI -0.067至-0.001,p=0.043)。在224例随访患者中,65例发生表型转化,转化者左侧DTI-ALPS指数更低(平均差-0.050,95%CI -0.098至-0.003,p=0.038),且较低左侧DTI-ALPS指数与转化为PD风险增加相关(HR=2.43,95%CI 1.13-5.25,p=0.012)。

要点

  • iRBD患者左侧DTI-ALPS指数较对照降低,提示类淋巴功能改变。
  • 较低左侧DTI-ALPS指数与iRBD向PD转化风险增加相关(HR=2.43)。
  • DTI-ALPS或可作为前驱期突触核蛋白病进展的预后MRI生物标志物。

核心结论

  • iRBD患者DTI-ALPS指数降低,且较低左侧DTI-ALPS指数与未来转化为PD的风险增加独立相关。

研究设计与样本

  • 纵向多中心队列研究,纳入5个国际中心经多导睡眠图确诊的iRBD患者和健康对照,所有参与者接受T1加权和弥散加权MRI。

主要发现

  • iRBD患者左侧DTI-ALPS指数低于对照(平均差=-0.034,95%CI -0.067至-0.001;p=0.043)。
  • 224例iRBD患者平均随访6.1±3.5年,65例发生突触核蛋白病表型转化。
  • 转化者左侧DTI-ALPS指数低于未转化者(平均差=-0.050,95%CI -0.098至-0.003;p=0.038)。
  • 较低左侧DTI-ALPS指数与转化为PD风险增加相关(HR=2.43,95%CI 1.13-5.25;p=0.012)。
  • 其他弥散指标(各向异性分数、弥散率、自由水)在组间无差异。

临床怎么用

  • 对于iRBD患者,可考虑将DTI-ALPS指数作为评估向PD转化风险的辅助影像学标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND OBJECTIVES: Isolated REM sleep behavior disorder (iRBD) is the strongest prodromal marker of synucleinopathies, including Parkinson disease (PD) and dementia with Lewy bodies (DLB). Identifying brain biomarkers that predict progression and distinguish phenoconversion trajectories remains a challenge. The glymphatic system is involved in interstitial waste clearance, and its dysfunction has been associated with pathologic protein accumulation and neurodegeneration. Diffusion tensor imaging along the perivascular space (DTI-ALPS) has been proposed as a noninvasive proxy for glymphatic function. The aim of this study was to determine whether patients with iRBD show a reduced DTI-ALPS index compared with controls and whether a lower DTI-ALPS index predicts future phenoconversion to PD or DLB. METHODS: We conducted a longitudinal, multicenter cohort study using brain MRI scans from patients with polysomnography-confirmed iRBD and healthy controls recruited across 5 international centers. All participants underwent T1-weighted and diffusion-weighted MRI. DTI-ALPS indices were computed from diffusivity along projection and associative fibers adjacent to the lateral ventricles. The primary outcome was time to phenoconversion to synucleinopathy. Linear models assessed baseline group differences and clinical correlates, and Cox proportional hazard models assessed the predictive value of DTI-ALPS for time to phenoconversion. RESULTS: A total of 250 patients with iRBD (mean age: 66.5 ± 6.8 years; 87% male) and 178 controls (65.7 ± 6.8 years; 81% male) were included. Patients with iRBD showed a lower left DTI-ALPS index compared with controls (mean difference = -0.034, 95% CI -0.067 to -0.001; p = 0.043). Of 224 patients with iRBD followed for a mean of 6.1 ± 3.5 years, 65 phenoconverted to a synucleinopathy. Converters had a lower left DTI-ALPS index than nonconverters (mean difference = -0.050, 95% CI -0.098 to -0.003; p = 0.038). Lower left DTI-ALPS index was associated with an increased risk of conversion to PD over time (hazard ratio = 2.43, 95% CI 1.13-5.25; p = 0.012). Other diffusion metrics inside periventricular masks, namely fractional anisotropy, diffusivity metrics, and free water, did not differ between groups. DISCUSSION: Patients with iRBD exhibit a reduced DTI-ALPS index, suggesting altered glymphatic function. This reduction was associated with future phenoconversion to PD, supporting the DTI-ALPS index as a potential prognostic MRI biomarker of progression in prodromal synucleinopathies.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Ayral V, Pastor-Bernier A, Daneault V, et al. Association of DTI-ALPS Glymphatic Index With Differential Phenoconversion in Isolated REM Sleep Behavior Disorder: A Multi-Cohort MRI Study. Neurology. 2025. PMID: 40956987. doi:10.1212/WNL.0000000000214042

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。